Pediatric and Adolescent Melanoma: A National Cancer Data Base Update
- PMID: 27364504
- DOI: 10.1245/s10434-016-5349-2
Pediatric and Adolescent Melanoma: A National Cancer Data Base Update
Abstract
Background: Studies suggest that the biology of pediatric and adolescent melanoma differs from that of adult disease. We report the largest series to date examining the natural history of pediatric and adolescent melanoma. We aim to elucidate the natural history of pediatric and adolescent melanoma and to examine the appropriateness of diagnostic and therapeutic modalities developed for adults and that are currently being used in children.
Methods: A retrospective cohort study was conducted of patients with an index diagnosis of cutaneous non-metastatic melanoma from 1998 to 2011 using the National Cancer Data Base (NCDB; n = 420,416). Three age-based cohorts were analyzed: 1-10 years (pediatric), 11-20 years (adolescent), and ≥21 years (adult). Multivariate analyses were used to identify factors associated with overall survival (OS).
Results: Pediatric melanoma patients have longer OS than their adolescent (hazard ratio [HR] 0.50, 95 % CI 0.25-0.98) and adult counterparts (HR 0.11, 95 % CI 0.06-0.21). Adolescents have longer OS than adults. No difference was found in OS in pediatric patients who are node-positive versus node-negative. In pediatric patients, sentinel lymph node biopsy and completion lymph node dissection are not associated with increased OS. In adolescents, nodal positivity is a significant negative prognostic indicator (HR 4.82, 95 % CI 3.38-6.87).
Conclusions: Age-based differences in melanoma outcomes warrant different considerations for diagnostic and therapeutic approaches in each group in order to maximize quality of life while minimizing complications and costs. Prospective, multicenter studies should evaluate the role of diagnostic procedures for pediatric patients.
Similar articles
-
Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients.Ann Surg. 2011 Jun;253(6):1211-5. doi: 10.1097/SLA.0b013e318217e852. Ann Surg. 2011. PMID: 21451389
-
Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.Plast Reconstr Surg. 2003 Aug;112(2):486-97. doi: 10.1097/01.PRS.0000070989.23469.1F. Plast Reconstr Surg. 2003. PMID: 12900606
-
Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.Cancer. 2012 Feb 15;118(4):1040-7. doi: 10.1002/cncr.26288. Epub 2011 Jul 19. Cancer. 2012. PMID: 21773971
-
Sentinel lymph node biopsy in melanoma: controversies and current guidelines.Future Oncol. 2014 Feb;10(3):429-42. doi: 10.2217/fon.13.245. Future Oncol. 2014. PMID: 24559449 Review.
-
Prognostic heterogeneity after the excision of lymph node metastases in patients with cutaneous melanoma.Surg Oncol. 2011 Mar;20(1):26-34. doi: 10.1016/j.suronc.2009.09.004. Epub 2009 Nov 8. Surg Oncol. 2011. PMID: 19900803 Review.
Cited by
-
Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review.Pediatr Surg Int. 2024 Mar 5;40(1):68. doi: 10.1007/s00383-024-05646-8. Pediatr Surg Int. 2024. PMID: 38441654 Free PMC article.
-
Increased incidence of melanoma in children and adolescents in Finland in 1990-2014: nationwide re-evaluation of histopathological characteristics.Ann Med. 2022 Dec;54(1):244-252. doi: 10.1080/07853890.2022.2026001. Ann Med. 2022. PMID: 35037531 Free PMC article.
-
Giant congenital nodular melanoma in a newborn: a case report and literature review.BMC Pediatr. 2021 Mar 11;21(1):121. doi: 10.1186/s12887-021-02590-7. BMC Pediatr. 2021. PMID: 33706747 Free PMC article. Review.
-
Role of sentinel lymph node biopsy for cutaneous melanoma in elderly patients: preliminary results in a Latin-American population.Ecancermedicalscience. 2021 Jan 13;15:1167. doi: 10.3332/ecancer.2021.1167. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33680081 Free PMC article.
-
Beta2 glycoprotein I-derived therapeutic peptides induce sFlt-1 secretion to reduce melanoma vascularity and growth.Cancer Lett. 2020 Dec 28;495:66-75. doi: 10.1016/j.canlet.2020.08.039. Epub 2020 Sep 4. Cancer Lett. 2020. PMID: 32891714 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical